Intrinsic Alpha

Elevance Health Inc.

NYSE:ELV

Medical - Healthcare Plans

Healthcare
$394.48 -0.88%

-$3.45 today

Market cap
$85.23B
Beta
0.68
P/E (TTM)
16.3
EPS (TTM)
$23.78
Dividend yield
1.77%
52W Low $273.71High $426.98

Volume 2.04M

Average 1.68M

Returns on capital

Elevance Health Inc. management

Start with the returns management earns on the capital it controls, then review the people, their trades, and growth quality.

Return Metrics

ROE, ROIC & ROA over time

Management
Older years hidden. Sign in to unlock

ROE

12.9%

avg 13.9%

ROIC

6.6%

avg 6.9%

ROA

4.7%

avg 5.2%

Analysis

ROE is currently the strongest return metric at 12.9% versus its period average of 13.9%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.

Leadership

Who runs the company?

Review the executive team, tenure, compensation, and ownership.

Management

Key executives, compensation & ownership

NameTitleCompensationAgeShares OwnedOwnership %

Gail Koziara Boudreaux

President, Chief Executive Officer & DirectorUSD 4.94M65——

Peter David Haytaian

Special AdvisorUSD 2.06M56——

Felicia Farr Norwood

Executive VP & Chief Health Benefits OfficerUSD 2.03M66——

Mark Bradley Kaye

Executive Vice President & Chief Financial OfficerUSD 2.01M46——

Charles Morgan Kendrick Jr.

EVP and President of Commercial & Specialty Health BenefitsUSD 1.91M6011.79K<0.01%

Nathan Allen Rich

Vice President of Investor Relations————

Ronald William Penczek

Senior Vice President, Controller & Chief Accounting Officer—61——

Scott Wayne Anglin

SVP, Treasurer & Chief Investment Officer————

Erin Wessling

Executive VP & Chief Legal Officer—48——

Julie Goon

Senior Vice President of Public Affairs————

Compensation is shown in the reported currency; data updated Nov 7, 2026.

Ownership uses each executive's latest SEC Form 4 holding only when the full name maps to one reporting CIK; latest matched holding Mar 6, 2026.

Insider trading

Are insiders buying or selling?

Follow recent insider purchases and sales reported on Form 4.

Insider Trading

SEC Form 4 transactions — last 12 months

Buys

4

$2.24M

Sells

19

$6.98M

Net Transaction Value

−$4.74M

Net selling

Most Active

Kaye Mark

13 transactions

Transactions sorted by date, descending.

Open-market insider purchases and sales reported during the last 12 months
Type
Nov 5, 26

LAVU RATNAKAR

Direct

Sell$572K
Oct 22, 26

Kaye Mark

Direct

Sell$139.7K
Oct 22, 26

Kaye Mark

Direct

Sell$724.1K
Oct 22, 26

Kaye Mark

Direct

Sell$244.8K
Oct 22, 26

Kaye Mark

Direct

Sell$105.2K
Oct 22, 26

Kaye Mark

Direct

Sell$509.5K
Oct 22, 26

Kaye Mark

Direct

Sell$757.6K
Oct 22, 26

Kaye Mark

Direct

Sell$1M
Oct 22, 26

Kaye Mark

Direct

Sell$212.5K
Oct 22, 26

Kaye Mark

Direct

Sell$195.3K

1–10 of 23

Summary

Insiders reported 4 buys worth $2.24M and 19 sells worth $6.98M over the last 12 months. That adds up to net selling of $4.74M. Kaye Mark was the most active insider with 13 transactions.

Growth analysis

Is management growing the business?

Compare historical growth with analyst forecasts across revenue, earnings, and cash flow.

Growth Analysis

Historical CAGR & forward analyst estimates

Metric 10yr 5yr3yr Fwd Est.
EPSN/AN/A+1.1%
+13.1% (5yr)1 analysts
RevenueN/AN/A+8.3%
+3.6% (5yr)5 analysts
Net IncomeN/AN/A-1.3%
+12.7% (5yr)5 analysts
EBITN/AN/A-1.4%
+12.0% (5yr)5 analysts

Analysis

Recent growth has been strongest in Revenue at +8.3% over three years. Forward estimates point to EPS at +13.1% (5yr), giving you a quick check on whether expectations are accelerating or cooling.

Competitors

Who does Elevance Health Inc. compete with?

Open similar companies to compare how their management teams allocate capital.

Questions

Management questions

Common questions about ELV's management, answered from reported figures.

Who manages ELV?

Elevance Health Inc. (ELV) lists 10 active executives. The top listed executive is Charles Morgan Kendrick Jr., EVP and President of Commercial & Specialty Health Benefits.

Are ELV insiders buying or selling?

Recent insider activity shows net buying of $37.06M.